Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries

• Status: Withdrawn
• Trial end date: 2019-07-12
• Target enrollment: 0
• Participant gender: Female

Summary

This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: American University of Beirut Medical Center
• Treatments: Ascorbic Acid; Vitamins

Criteria

Inclusion Criteria:

Non pregnant women at least 18 years of age visiting the Preadmission unit (PAU) or the OBGYN floor (7N), presenting for elective GYN surgery at the American University of Beirut Medical Center (AUBMC).

Exclusion Criteria:

• Any women with the following:

1. Nephrolithiasis

2. Congenital anomaly or neurogenic bladder

3. Allergy to ascorbic acid

4. Who require therapeutic anticoagulant medicine during the 6 weeks after surgery

5. Surgery did involve a fistula repair or a vaginal mesh removal

6. Positive Urinalysis in the PAU

7. Recurrent UTI's

8. Diabetes

9. G6PD

10. Hemochromatosis

11. Renal disorders

Patients already taking Vitamin C supplementation will also be excluded from the study.